AIP
DXB.CL

Almanack Investment Partners’s Deutsche Bank Contingent Capital Trust II 6.55% Trust Preferred Securities Called DXB.CL Stock Holding History

Almanack Investment Partners’s Portfolio DXB.CL Stock Details DXB.CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,150
Closed -$130K – 309
2019
Q2 		$130K Buy
+5,150
New +$129K 0.03% 232

Other funds holding DXB.CL

BRC
Bell Rock Capital Rehoboth Beach, Delaware $81M AUM 9.85% 1-Year Est. Return
PCG
Private Capital Group West Hartford, Connecticut $133M AUM 11.23% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Almanack Investment Partners's DXB.CL Position: Q3 2019 in Review

Almanack Investment Partners sold out of Deutsche Bank Contingent Capital Trust II 6.55% Trust Preferred Securities Called (DXB.CL) in Q3 2019, closing a stake of 5,150 shares — an estimated $130K sold.

Almanack Investment Partners first reported a position in DXB.CL in Q2 2019 and held it in 1 quarter. The position peaked at $130K in Q2 2019. 3 funds tracked by Wall St. Rank hold DXB.CL as of Q3 2019.

  • Almanack Investment Partners reported no remaining Deutsche Bank Contingent Capital Trust II 6.55% Trust Preferred Securities Called position as of Q3 2019 after selling out during the quarter.
  • Almanack Investment Partners sold 5,150 Deutsche Bank Contingent Capital Trust II 6.55% Trust Preferred Securities Called shares in Q3 2019, an estimated $130K.
  • Almanack Investment Partners first reported a position in Deutsche Bank Contingent Capital Trust II 6.55% Trust Preferred Securities Called in Q2 2019 and held it in 1 quarter.
  • Almanack Investment Partners's Deutsche Bank Contingent Capital Trust II 6.55% Trust Preferred Securities Called position peaked at $130K in Q2 2019.
  • 3 funds tracked by Wall St. Rank held Deutsche Bank Contingent Capital Trust II 6.55% Trust Preferred Securities Called as of Q3 2019.

Based on Almanack Investment Partners's 13F filing for Q3 2019, filed 8 Nov 2019.